{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:56:13Z","timestamp":1772942173235,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"9","funder":[{"DOI":"10.13039\/501100002908","name":"Stichting Combined Ophthalmic Research Rotterdam","doi-asserted-by":"publisher","award":["3.1.0"],"award-info":[{"award-number":["3.1.0"]}],"id":[{"id":"10.13039\/501100002908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1136\/bjophthalmol-2016-309134","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T02:39:02Z","timestamp":1484188742000},"page":"1285-1289","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Preoperative aqueous humour flare values do not predict proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment"],"prefix":"10.1136","volume":"101","author":[{"given":"Verena C","family":"Mulder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elon HC","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantine","family":"Purtskhvanidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Roider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C","family":"van Meurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Treumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-309134-1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","article-title":"Proliferative vitreoretinopathy: an overview","volume":"43","author":"Pastor","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-2","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/aos.12429","article-title":"Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial","volume":"93","author":"Ahmadieh","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","article-title":"Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group","volume":"126","author":"Wiedemann","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0161-6420(01)00589-9","article-title":"Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial","volume":"108","author":"Asaria","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309134-5","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ophtha.2008.05.016","article-title":"Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial","volume":"115","author":"Ahmadieh","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309134-6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ophtha.2006.08.042","article-title":"Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy","volume":"114","author":"Wickham","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309134-7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.ophtha.2004.05.036","article-title":"A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy","volume":"111","author":"Charteris","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309134-8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/bjo.84.5.506","article-title":"Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study","volume":"84","author":"Kon","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1350-9462(01)00023-4","article-title":"Proliferative vitreoretinopathy: risk factors and pathobiology","volume":"21","author":"Pastor","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2016-309134-10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bjophthalmol-2014-305263","article-title":"Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables","volume":"99","author":"Rojas","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-11","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1111\/aos.12718","article-title":"BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project","volume":"93","author":"Pastor-Idoate","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/IAE.0b013e31828991ea","article-title":"External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: the Retina 1 Project; report 5","volume":"33","author":"Sala-Puigdollers","year":"2013","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309134-13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/IAE.0b013e3182173753","article-title":"Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment","volume":"32","author":"Schroder","year":"2012","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309134-14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-010-1319-8","article-title":"The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial","volume":"248","author":"Bali","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9394(01)01026-1","article-title":"Randomized clinical trial of cryotherapy versus laser photocoagulation for retinopexy in conventional retinal detachment surgery","volume":"132","author":"Veckeneer","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjo.75.6.348","article-title":"Measurement of aqueous cells and flare in normal eyes","volume":"75","author":"Shah","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-17","first-page":"362","article-title":"Effect of commercial dilating agents on laser flare-cell measurements","volume":"31","author":"Chin","year":"1996","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-18","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/IAE.0b013e3182456f38","article-title":"Time course of changes in aqueous flare intensity after vitrectomy for rhegmatogenous retinal detachment","volume":"32","author":"Hoshi","year":"2012","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2016-309134-19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.survophthal.2004.10.004","article-title":"Laser flare-cell photometry: methodology and clinical applications","volume":"50","author":"Ladas","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309134-20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0886-3350(99)00404-6","article-title":"Effect of tropicamide on aqueous flare before and after cataract surgery","volume":"26","author":"Petternel","year":"2000","journal-title":"J Cataract Refract Surg"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-309134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:53:29Z","timestamp":1601110409000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-309134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,8,23]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/bjophthalmol-2016-309134"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309134","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}